U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Compositions containing histamine-H2-receptor antagonists at low dosage

Patent 5629026 Issued on May 13, 1997. Estimated Expiration Date: Icon_subject May 17, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Effervescent couples, histamine H2 -antagonist effervescent compositions containing them and their preparation
Patent #: 4824664
Issued on: 04/25/1989
Inventor: Tarral ,   et al.

Pharmaceutical formulations
Patent #: 4996222
Issued on: 02/26/1991
Inventor: Carlin, et al.

Pharmaceutical compositions of cimetidine
Patent #: 5057319
Issued on: 10/15/1991
Inventor: Gottwald, et al.

Pharmaceutical compositions
Patent #: 5169640
Issued on: 12/08/1992
Inventor: France, et al.

Pharmaceutical compositions of cimetidine
Patent #: 5188839
Issued on: 02/23/1993
Inventor: Pearmain

Pharmaceutical compositions
Patent #: 5275823
Issued on: 01/04/1994
Inventor: France, et al.

Pharmaceutical compositions containing furan derivatives Patent #: 5456925
Issued on: 10/10/1995
Inventor: Smith, et al.

Inventor

Assignee

Application

No. 443290 filed on 05/17/1995

US Classes:

424/686, Carbonate or bicarbonate424/605, Phosphorus acid424/653, Bismuth424/683, Magnesium silicate424/684, Aluminum silicate424/687, Calcium carbonate424/690, Aluminum hydroxide424/692, Magnesium hydroxide or oxide514/370, Nitrogen bonded directly to ring carbon of the thiazole ring514/400, At imidazole ring carbon514/471, Nitrogen containing514/544, C(=O)O attached directly through the carbon to a benzene ring514/547, Compound contains two or more C(=O)O groups514/549Z radical contains carbon to carbon unsaturation

Examiners

Primary: Geist, Gary
Assistant: Frazier, Barbara S.

Attorney, Agent or Firm

International Classes

A61K 033/10
A61K 031/425

Foreign Application Priority Data

1991-12-20 GB

Abstract

Compositions for oral administration for the treatment of gastric disorders comprising histamine H2 -receptor antagonist and antacid, optionally buffered to promote local absorption of the H2 -receptor antagonist, wherein the quantity of H2 -receptor antagonist per unit dosage form is less than 25 mg.

PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?